Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 ...
Han WONG | Consultant Medical Oncologist | MB ChB, PhD, FRCP | Cambridge University Hospitals NHS Foundation Trust, Cambridge | Addenbrooke's Hospital | Research profile
Ioannis Gounaris's Email & Phone - The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
Professor Steve Charnock-Jones
Ioannis Gounaris | LinkedIn
Scientific Meeting “The Refugees of 1922”
Ioannis Gounaris | LinkedIn
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals | Research profile
Ioannis Gounaris | LinkedIn
Ioannis Gounaris | LinkedIn
Ioannis Gounaris | LinkedIn
Ioannis Gounaris | LinkedIn
Pavel MOZGUNOV | Advanced Research Fellow | PhD in Statistics | University of Cambridge, Cambridge | Cam | MRC Biostatistics Unit | Research profile
Ioannis Gounaris | LinkedIn
Ioannis Gounaris (GRE) :: Photos :: playmakerstats.com
Ioannis Gounaris | LinkedIn
Ιωάννης Σ. Κολιόπουλος: Η Ιστορία και οι χρήσεις της – Clio Turbata
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals | Research profile
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals | Research profile
Ioannis Gounaris | LinkedIn
Ioannis FLESSAS | Consultant | MD, MSc, PhD, FEBS, FACS | Henry Dunant Hospital, Athens | C Breast Clinic | Research profile
Ioannis GOUNARIS | Merck, Darmstadt | Pharmaceuticals | Research profile
Ioannis Gounaris's Email & Phone - The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
